Immuneering Corp
NASDAQ:IMRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
Repay Holdings Corp
NASDAQ:RPAY
|
US |
|
L
|
L3harris Technologies Inc
F:HRS
|
US |
|
Aptiv PLC
NYSE:APTV
|
IE |
|
Synnex Technology International Corp
TWSE:2347
|
TW |
|
Spotify Technology SA
NYSE:SPOT
|
LU |
|
Sika AG
F:SIKA
|
CH |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
Wayfair Inc
NYSE:W
|
US |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
V
|
Vector Group Ltd
SWB:VGR
|
US |
|
S&T Bancorp Inc
NASDAQ:STBA
|
US |
|
Globe Life Inc
NYSE:GL
|
US |
|
Novartis AG
SIX:NOVN
|
CH |
|
T
|
Toshiba Corp
XBER:TSE1
|
JP |
|
Arhaus Inc
NASDAQ:ARHS
|
US |
Bankruptcy Probability
Immuneering Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Immuneering Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
Immuneering Corp
NASDAQ:IMRX
|
348.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Immuneering Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Immuneering Corp has no debt.
You can find a full breakdown on its Balance Sheet.
